Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2019 - 2025)

Dianthus Therapeutics (DNTH) has 5 years of Amortizatization of Intangibles data on record, last reported at $4.1 million in Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles rose 75.31% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $2.3 million, down 22.95%, while the annual FY2024 figure was $316000.0, 77.79% down from the prior year.
  • Amortizatization of Intangibles reached $4.1 million in Q3 2025 per DNTH's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.1 million in Q3 2025 and bottomed at -$3.0 million in Q4 2024.
  • Average Amortizatization of Intangibles over 4 years is $426466.7, with a median of $106000.0 recorded in 2025.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 662.62% in 2024, then skyrocketed 1147.73% in 2025.
  • A 4-year view of Amortizatization of Intangibles shows it stood at -$87000.0 in 2022, then surged by 705.75% to $527000.0 in 2023, then tumbled by 662.62% to -$3.0 million in 2024, then soared by 238.41% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $4.1 million in Q3 2025, $1.1 million in Q2 2025, and $106000.0 in Q1 2025.